Private Foundation · NJ
Novartis Patient Assistance Foundation
East Hanover, NJ · EIN 262502555 · Website ↗ · 990s on ProPublica ↗
Assets
$382.9M
Total Giving
$11.6B
Grants on File
4
Average Grant
$2.9B
Giving Radius
Where Novartis Patient Assistance Foundation Has Given
Section I
How to Apply
The Novartis Patient Assistance Foundation, Inc (NPAF) is committed to providing access to Novartis medications for those most in need. If you are experiencing financial hardship and have limited or no prescription coverage, then you may be eligible to receive Novartis medications for free. To enroll, please go to www.pap.novartis.com, select your medication from the list and follow the directions provided.
On Unsolicited Proposals yes
Restrictions
To be eligible for NPAF assistance, you must: - Be a US resident - Meet the program income requirements - Have limited or no private or public prescription coverage For more information regarding annual household income threshold requirements and a list of medications, please go to: WWW.PAP.NOVARTIS.COM
Section IV
Recent Grants
| Recipient | Amount | Year |
|---|---|---|
| East Hanover, NJ | $3.3B | 2020 |
| East Hanover, NJ | $2.5B | 2021 |
| East Hanover, NJ | $2.9B | 2023 |
| East Hanover, NJ | $2.9B | 2022 |
4 grants total
Section VI
Filing History
Year-by-year financial summary from IRS 990-PF filings. Total assets and qualifying distributions show the foundation's growth and giving trajectory.
| Year | Total Assets | Qualifying Distributions | Total Revenue | Total Expenses |
|---|---|---|---|---|
| 2023 | $177.0M | — | $2.8B | $2.9B |
| 2022 | $290.2M | — | $3.1B | $2.9B |
| 2021 | $159.7M | — | $2.5B | $2.6B |
| 2020 | $214.1M | — | $3.4B | $3.3B |
| 2019 | $124.5M | — | $1.9B | $1.9B |
| 2015 | $55.2M | — | $570.4M | $551.2M |
| 2014 | $36.0M | — | $465.5M | $462.0M |
| 2013 | $32.5M | — | $460.7M | $459.8M |
| 2012 | $31.6M | — | $468.0M | $459.7M |
| 2011 | $23.3M | — | $345.4M | $338.8M |
Section VII
Foundations Like This One
Similar in focus area, location, and asset size. Worth researching as part of the same campaign.